PP_1170x120_10-25-21

Syprine

Dr. Reddy’s launches trientine hydrochloride capsules

Dr. Reddy’s launches trientine hydrochloride capsules

PRINCETON, N.J. — Dr. Reddy’s announced the launch of trientine hydrochloride capsules USP, 250 mg, a therapeutically equivalent generic version of Syprine (trientine hydrochloride) Capsules, approved by the U.S. Food and Drug Administration. “We are pleased to provide this convenient alternative for patients, pharmacists and distribution partners,” explains Marc Kikuchi, chief executive officer and head

Adheris Health